Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
202.83 USD | +0.21% | +5.09% | +26.51% |
09-13 | T-MOBILE US : JP Morgan gives a Buy rating | ZD |
09-12 | Top Midday Stories: Moderna Shares Tumble on R&D Expense Cuts; Mastercard to Buy Recorded Future for $2.65 Billion | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 43.83B | 67.71B | 79.1B | 78.45B | 77.38B | |||||
Other Revenues, Total | 1.16B | 690M | 1.02B | 1.12B | 1.18B | |||||
Total Revenues | 45B | 68.4B | 80.12B | 79.57B | 78.56B | |||||
Cost of Goods Sold, Total | 18.52B | 27.61B | 34.57B | 32.01B | 29.41B | |||||
Gross Profit | 26.48B | 40.78B | 45.55B | 47.56B | 49.15B | |||||
Selling General & Admin Expenses, Total | 13.52B | 17.21B | 19.17B | 20.83B | 20.53B | |||||
Depreciation & Amortization - (IS) | 6.62B | 14.15B | 16.38B | 13.65B | 12.82B | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 20.14B | 31.36B | 35.55B | 34.48B | 33.34B | |||||
Operating Income | 6.34B | 9.42B | 9.99B | 13.08B | 15.81B | |||||
Interest Expense, Total | -1.14B | -2.73B | -3.36B | -3.36B | -3.34B | |||||
Interest And Investment Income | 24M | 29M | 20M | - | - | |||||
Net Interest Expenses | -1.11B | -2.7B | -3.34B | -3.36B | -3.34B | |||||
Other Non Operating Income (Expenses) | -8M | -27M | -10M | -39M | -2M | |||||
EBT, Excl. Unusual Items | 5.22B | 6.69B | 6.64B | 9.68B | 12.47B | |||||
Restructuring Charges | - | - | - | - | -462M | |||||
Merger & Related Restructuring Charges | -620M | -1.92B | -3.11B | -4.97B | -1.03B | |||||
Impairment of Goodwill | - | -218M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | -1.09B | 25M | |||||
Asset Writedown | - | -200M | - | -477M | - | |||||
Insurance Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | -829M | -184M | - | - | |||||
EBT, Incl. Unusual Items | 4.6B | 3.53B | 3.35B | 3.15B | 11B | |||||
Income Tax Expense | 1.14B | 786M | 327M | 556M | 2.68B | |||||
Earnings From Continuing Operations | 3.47B | 2.74B | 3.02B | 2.59B | 8.32B | |||||
Earnings Of Discontinued Operations | - | 320M | - | - | - | |||||
Net Income to Company | 3.47B | 3.06B | 3.02B | 2.59B | 8.32B | |||||
Net Income - (IS) | 3.47B | 3.06B | 3.02B | 2.59B | 8.32B | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 3.47B | 3.06B | 3.02B | 2.59B | 8.32B | |||||
Net Income to Common Excl. Extra Items | 3.47B | 2.74B | 3.02B | 2.59B | 8.32B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.06 | 2.68 | 2.42 | 2.07 | 7.02 | |||||
Basic EPS - Continuing Operations | 4.06 | 2.4 | 2.42 | 2.07 | 7.02 | |||||
Basic Weighted Average Shares Outstanding | 854M | 1.14B | 1.25B | 1.25B | 1.19B | |||||
Net EPS - Diluted | 4.02 | 2.65 | 2.41 | 2.06 | 6.93 | |||||
Diluted EPS - Continuing Operations | 4.02 | 2.37 | 2.41 | 2.06 | 6.93 | |||||
Diluted Weighted Average Shares Outstanding | 863M | 1.15B | 1.25B | 1.26B | 1.2B | |||||
Normalized Basic EPS | 3.82 | 3.66 | 3.33 | 4.84 | 6.58 | |||||
Normalized Diluted EPS | 3.78 | 3.62 | 3.31 | 4.82 | 6.49 | |||||
Dividend Per Share | - | - | - | - | 1.3 | |||||
Payout Ratio | - | - | - | - | 8.98 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 12.96B | 23.57B | 26.38B | 26.73B | 28.62B | |||||
EBITA | 6.42B | 10.62B | 11.29B | 14.28B | 16.7B | |||||
EBIT | 6.34B | 9.42B | 9.99B | 13.08B | 15.81B | |||||
EBITDAR | 15.76B | 28.34B | 32.73B | 33.73B | 34.02B | |||||
Total Revenues (As Reported) | 45B | 68.4B | 80.12B | 79.57B | 78.56B | |||||
Effective Tax Rate - (Ratio) | 24.66 | 22.27 | 9.76 | 17.67 | 24.38 | |||||
Current Domestic Taxes | 44M | 67M | 111M | 42M | 70M | |||||
Current Foreign Taxes | - | 10M | 19M | 22M | 12M | |||||
Total Current Taxes | 44M | 77M | 130M | 64M | 82M | |||||
Deferred Domestic Taxes | 1.09B | 710M | 214M | 551M | 2.57B | |||||
Deferred Foreign Taxes | - | -1M | -17M | -59M | 33M | |||||
Total Deferred Taxes | 1.09B | 709M | 197M | 492M | 2.6B | |||||
Normalized Net Income | 3.26B | 4.18B | 4.15B | 6.05B | 7.79B | |||||
Interest Capitalized | 473M | 440M | 210M | 61M | 104M | |||||
Interest on Long-Term Debt | 963M | 768M | 452M | 129M | 183M | |||||
Non-Cash Pension Expense | - | 7M | 5M | -6M | -70M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 1.6B | - | - | - | - | |||||
Marketing Expenses | - | 1.8B | 2.2B | 2.3B | 2.5B | |||||
Selling and Marketing Expenses | 1.6B | 1.8B | 2.2B | 2.3B | 2.5B | |||||
Research And Development Expense From Footnotes | - | 200M | - | - | - | |||||
Net Rental Expense, Total | 2.8B | 4.77B | 6.35B | 7B | 5.4B | |||||
Imputed Operating Lease Interest Expense | 973M | 1.6B | 1.68B | 1.74B | 1.31B | |||||
Imputed Operating Lease Depreciation | 1.83B | 3.16B | 4.67B | 5.26B | 4.08B | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 495M | 694M | 540M | 596M | 667M | |||||
Total Stock-Based Compensation | 495M | 694M | 540M | 596M | 667M |